Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
about
The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis.The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity?Molecular mechanisms of the preventable causes of cancer in the United States
P2860
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
@en
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
@nl
type
label
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
@en
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
@nl
prefLabel
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
@en
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
@nl
P2093
P2860
P356
P1476
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening
@en
P2093
Barbara Fetterman
Brian Befano
Hormuzd A Katki
John Schussler
Julia C Gage
Li C Cheung
Mark Schiffman
Nancy E Poitras
Nicolas Wentzensen
Philip E Castle
P2860
P304
P356
10.1093/JNCI/DJX225
P407
P577
2017-11-14T00:00:00Z